References
- Åberg A. Socialstyrelsen. Cancer incidence in Sweden 2010. Sveriges officiella statistik. Hälso- och Sjukvård 2011;29.
- Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst 2010;102:950–8.
- Egevad L, Algaba F, Berney DM, Boccon-Gibod L, Griffiths DF, Lopez-Beltran A, The European Network of Uropathology: a novel mechanism for communication between pathologists. Anal Quant Cytol Histol 2009;31:90–5.
- Duffield AS, Lee TK, Miyamoto H, Carter HB, Epstein JI. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol 2009;182:2274–8.
- Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. Eur Urol 2010;58:851–64.
- Ching CB, Moussa AS, Li J, Lane BR, Zippe C, Jones JS. Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates. J Urol 2009;181:2077–82; discussion 82–3.
- Mortimer AM, Ridley N, Cook JL. The influence of ultrasound probe orientation on prostate cancer detection rate during transrectal ultrasonography-guided prostate biopsy. J Endourol 2010;24:2075–81.
- Ching CB, Zaytoun O, Moussa AS, Li J, Avallone A, Jones JS. Type of transrectal ultrasonography probe influences prostate cancer detection rates on repeat prostate biopsy. BJU Int 2011 Nov 1; doi: 10.1111/j.1464-410X.2011.10689.x.
- Paul R, Korzinek C, Necknig U, Niesel T, Alschibaja M, Leyh H, Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate. Urology 2004;64:532–6.
- Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61–71.
- Lee G, Attar K, Laniado M, Karim O. Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 2007;39:185–8.
- Inal G, Yazici S, Adsan O, Ozturk B, Kosan M, Cetinkaya M. Effect of periprostatic nerve blockade before transrectal ultrasound-guided prostate biopsy on patient comfort: a randomized placebo controlled study. Int J Urol 2004;11:148–51.
- Addla SK, Adeyoju AA, Wemyss-Holden GD, Neilson D. Local anaesthetic for transrectal ultrasound-guided prostate biopsy: a prospective, randomized, double blind, placebo-controlled study. Eur Urol 2003;43:441–3.
- Zani EL, Clark OA, Rodrigues Netto N Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 2011;CD006576.
- Egevad L, Allsbrook WC Jr, Epstein JI. Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists. Hum Pathol 2006;37:292–7.
- Franzen S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. Br J Urol 1960;32:193–6.
- Lane RB Jr, Lane CG, Mangold KA, Johnson MH, Allsbrook WC Jr. Needle biopsies of the prostate: what constitutes adequate histologic sampling? Arch Pathol Lab Med 1998;122:833–5.
- Amin M, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 2005;20–33.
- Biedrzycki O, Varma M, Berney DM. Variations in the processing of prostatic needle cores in the UK; what is safe? J Clin Pathol 2003;56:341–3.
- Vickers AJ, Savage CJ, Shouery M, Eastham JA, Scardino PT, Basch EM. Study of a web-based assessment of functional recovery after radical prostatectomy. Health Qual Life Outcomes 2010;8:82.
- Matteson KA, Anderson BL, Pinto SB, Lopes V, Schulkin J, Clark MA. Surveying ourselves: examining the use of a web-based approach for a physician survey. Eval Health Prof 2011;34:448–63.